The Society for Maternal-Fetal Medicine (SMFM), hosted a two-day workshop entitled 'Reproductive Services for Women at High Risk for Maternal Mortality.' The workshop was held in conjunction with SMFM's 39th Annual Pregnancy Meeting in February 2019 and was co-sponsored by the American College of Obstetricians and Gynecologists, Fellowship in Family Planning, and Society of Family Planning. A summary of the workshop and its recommendations has been published in the American Journal of Obstetrics and Gynecology.
Researchers have unlocked mysteries surrounding how a pregnant mother's cells and her fetus' cells communicate throughout pregnancy. With this new information, The University of Texas Medical Branch at Galveston team and their colleagues in South Korea can develop new non-invasive methods of monitoring and improving the health of the fetus using this mode of communication.
The association between type 2 diabetes and increased fracture risk is well documented. However, little was known about the possible effect of family history of diabetes on bone mineral density (BMD). A study from China now confirms that a history of first-degree family members with diabetes is linked to increased BMD as well as to insulin resistance. Results are published online in Menopause, the journal of The North American Menopause Society (NAMS).
Iron deficiency in pregnancy is a common problem that often goes unrecognized and untreated due to a lack of knowledge of its implications and competing clinical priorities. To enhance screening and management of iron deficiency in pregnancy, a research team at Toronto's St. Michael's Hospital developed a quality improvement toolkit, called IRON MOM. The implementation of IRON MOM resulted in increased rates of ferritin testing and decreased rates of anemia at St. Michael's obstetric clinics.
A small but concerning number of women are exposed to a commonly used MRI contrast agent early in their pregnancy, likely before many of them are aware that they're pregnant, according to a new study. The results support adherence to effective pregnancy screening measures to help reduce inadvertent exposures to these contrast agents during early pregnancy.
A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.
A new study shows that the risk of giving birth to a child with microcephaly might be related to how the immune system reacts against the Zika virus -- specifically what kind of antibodies it produces.
Hormone changes are known to alter insulin sensitivity and glucose metabolism, as well as interfere with women's sleep patterns. But little was known about the association between diabetes and sleep disturbances during the menopause transition until now, as a new study concludes that women with diabetes are at greater risk for sleep disturbances. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Infants born to mothers taking naltrexone to treat opioid use disorder during pregnancy developed no signs of neonatal opioid withdrawal syndrome (NOWS) during their hospitalization, a new study shows. In comparison to infants of mothers taking buprenorphine during pregnancy, infants exposed to naltrexone had shorter hospital stays, and mothers reported no use of other opioids during their pregnancy.
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries. New research by the University of Maryland School of Medicine (UMSOM) shows how the microbiome can either protect or make a woman more susceptible to these serious infections.